MME and heart failure: NEP inhibitors including sacubitril, RB‐101, omapatrilat, ecadotril, and candoxatril are rarely used alone but used in combination with AngII receptor blockers (ARBs) in the management of heart failure through modulation of RAS and expression of natriuretic peptides (Figure 2).